Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial entities : Applied genetic technologies corporation save search
AGTC to Present Three-Month Interim Results from the SKYLINE Clinical Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosa at the 45th Macula Society Annual Meeting
Published: 2022-06-06 (Crawled : 17:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: 2.04%
H: 2.5%
C: -1.5%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 2.06%
H: 0.24%
C: -1.95%
agtc-501 treatment trial
Positive 18-Month Data from Ongoing Phase 1/2 Clinical Study of AGTC-501 Presented at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting
Published: 2022-05-04 (Crawled : 17:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: -0.8%
H: 0.0%
C: -1.2%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 0.48%
H: 1.8%
C: -4.96%
agtc-501 ongoing research positive phase 1
AGTC to Showcase Interim Findings from Ongoing XLRP and Achromatopsia Phase 1/2 Trials at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting
Published: 2022-04-04 (Crawled : 21:00) - globenewswire.com
OTIC | $0.077
|
Health Technology
|
| O: -0.41%
H: 0.41%
C: -1.24%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 0.0%
H: 3.67%
C: 0.0%
ongoing trials research phase 1
AGTC Exceeds Enrollment Target in SKYLINE Trial of AGTC-501 for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
Published: 2022-01-11 (Crawled : 14:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: 3.32%
H: 0.0%
C: 0.0%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 2.87%
H: 0.0%
C: 0.0%
enroll treatment
AGTC Presents Data from Ongoing Phase 1/2 Trial of AGTC-501 at Upcoming American Academy of Ophthalmology 2021 Annual Meeting
Published: 2021-11-12 (Crawled : 13:15) - globenewswire.com
OTIC | $0.077
|
Health Technology
|
| O: 2.38%
H: 0.0%
C: 0.0%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: 0.0%
ongoing phase 1 trial
AGTC Clinical Trial Investigators to Present Data from Ongoing XLRP and Achromatopsia Phase 1/2 Trials at the Fourteenth International Symposium on Retinal Degeneration
Published: 2021-09-28 (Crawled : 15:15) - agtc.com
OTIC | $0.077
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: -2.55%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 0.62%
H: 1.07%
C: -4.29%
ongoing phase 1 retina trials trial symposium
AGTC to Participate in Clinical Trials in Rare Diseases Conference Panel and Case Study
Published: 2021-09-09 (Crawled : 12:15) - agtc.com
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 1.33%
C: -0.67%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 1.49%
H: 2.35%
C: -0.29%
disease clinical trials trials trial conference rare
Greater Gift, AGTC, and 2020 On-site Partner To Honor & Celebrate Clinical Trial Participants and Provide Eye Exams to Underserved Children in the Local Community
Published: 2021-08-24 (Crawled : 13:15) - agtc.com
OTIC | $0.077
|
Health Technology
|
| O: 0.72%
H: 2.88%
C: 2.52%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 0.29%
H: 3.02%
C: 2.3%
eye children trial
AGTC Reports 12-Month Data from its Ongoing Phase 1/2 Achromatopsia Clinical Trials Showing Biologic Activity in Patients with Mutations in the ACHM B3 Gene
Published: 2021-06-24 (Crawled : 12:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: -0.89%
H: 3.14%
C: 1.35%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 5.28%
H: 4.56%
C: -1.59%
ongoing clinical trials phase 1 trial phase 2
AGTC to Host Conference Call on June 24 at 8:00 AM ET to Discuss Achromatopsia 12-Month Data in its Ongoing CNGB3 and CNGA3 Phase 1/2 Clinical Trials
Published: 2021-06-23 (Crawled : 21:00) - biospace.com/
OTIC | $0.077
|
Health Technology
|
| O: 0.92%
H: 2.73%
C: 2.27%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 2.17%
H: 0.0%
C: -1.42%
ongoing clinical trials phase 1 trial conference
AGTC to Host Conference Call to Discuss Achromatopsia 12-Month Data in its Ongoing Phase 1/2 Clinical Trials
Published: 2021-06-23 (Crawled : 21:00) - agtc.com
OTIC | $0.077
|
Health Technology
|
| O: -0.89%
H: 3.14%
C: 1.35%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 5.28%
H: 4.56%
C: -1.59%
ongoing clinical trials phase 1 trial conference phase 2 phase 3
AGTC Clinical Investigators Provide Encore Presentation of Data from the Company’s Ongoing XLRP and Achromatopsia Phase 1/2 Trials
Published: 2021-05-03 (Crawled : 13:00) - globenewswire.com
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 3.66%
H: 0.11%
C: -6.04%
presentation ongoing phase 1 trial phase 3 phase 2
AGTC Announces Data to be Presented from the Ongoing XLRP and Achromatopsia Clinical Trials at the ARVO 2021 Virtual Annual Meeting
Published: 2021-04-29 (Crawled : 12:00) - globenewswire.com
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 3.12%
H: 1.86%
C: 0.0%
ongoing clinical trials trial
AGTC Announces New Initiatives To Enhance The Patient Journey In Its XLRP Trials
Published: 2021-03-30 (Crawled : 14:00) - agtc.com
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: -0.21%
H: 4.42%
C: 2.95%
trial
AGTC Announces New Initiatives To Enhance The Patient Journey In Its XLRP Trials
Published: 2021-03-25 (Crawled : 12:00) - biospace.com/
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: -3.35%
H: 8.57%
C: 7.55%
trial
AGTC Announces First Reported Improvements in Visual Sensitivity for Achromatopsia (ACHM) patients from its Ongoing Clinical Trials
Published: 2021-01-27 (Crawled : 22:00) - globenewswire.com
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: -4.04%
H: 1.87%
C: -7.49%
trial ongoing
Gainers vs Losers
| 63% | 37% |
Top 10 Gainers
CSSE 4 | $0.3686 142.02% 76M
|
Consumer Services
CZOO | $11.685 134.17% 7.6M
|
BOF | $1.93 64.96% 55M
|
AMST | $3.14 57.0% 59M
|
Technology Services
TROO | $1.57 44.04% 2.8M
|
Manufacturing
RILY | $30.87 42.13% 7.8M
|
Finance
LICN | $0.76 35.71% 6.2M
|
WHLM | $6.61 30.12% 400K
|
Commercial Services
MULN | News | $3.53 29.3% 4.8M
|
Information
RBBN 4 | $3.26 26.85% 1.2M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.